Medizinische Fachkraft
Bitte melden Sie sich an, um exklusive Informationen und Services zu erhalten.
Sind Sie neu hier?
Melden Sie sich für ein persönliches Konto an.

Press Releases

Explore the newest and archived press releases about AOP Orphan, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via publicaffairs@aoporphan.com 

AOP Orphan will host an Experts Press Conference at DGHO in Berlin

7. 10. 2019

AOP Orphan will host Industry Symposium at DGHO in Berlin

7. 10. 2019

AOP Orphan Pharmaceuticals AG, AOP Orphan IP AG and orphanix GmbH join forces to develop RetinolX to prevent bronchopulmonary dysplasia

13. 5. 2019

AOP Orphan announces EU Marketing Authorization for BESREMi® (Ropeginterferon alfa-2b) for rare blood cancer (PV)

21. 2. 2019

AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi®

17. 12. 2018

AOP Orphan announces three-year results on Ropeginterferon alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2018

3. 12. 2018

Press Conference

Find out about the upcoming and past AOP Orphan press conferences with details about topics, speakers, along with where and when. We will be happy to answer any questions or comments you may have via publicaffairs@aoporphan.com  

Experts Press Conference at DGHO
Location: CityCube Berlin, Messedamm 22 , Room R7, Level 3
Time: October 11th at 10am  -11am

 

Press Portfolios

Photos and Infographs

  • Infograph: Integrated care for rare diseases
    Bridging the gap to improve the lives of 30 million people in Europe.
    Infograph: Juggling care and daily life
    The balancing act of the rare disease community.
    Rare diseases seriously impact everyday life.

Contact

We believe that open communication is essential – not just in our day-to-day contact with business associates, but also with prospective partners, media, interested parties who are not yet familiar with AOP Orphan. We will be pleased to answer any questions you may have about the company, its products, studies, pipeline and overall plans.

Press contact

Lena Weissenbacher, BA
Corporate Communication Coordinator
+43 1 503 72 44 0
publicaffairs@aoporphan.com